Volume 17, Issue 6, Pages (June 2010)

Slides:



Advertisements
Similar presentations
Volume 14, Issue 6, Pages (June 2007)
Advertisements

Volume 16, Issue 1, Pages (January 2009)
Matthew D. Disney, Peter H. Seeberger  Chemistry & Biology 
Volume 11, Issue 8, Pages (August 2004)
Shoutian Zhu, Kevin T. Mc Henry, William S. Lane, Gabriel Fenteany 
Scratch n’ Screen for Inhibitors of Cell Migration
Volume 20, Issue 4, Pages (April 2013)
Volume 24, Issue 5, Pages e6 (May 2017)
Volume 18, Issue 11, Pages (November 2011)
Volume 28, Issue 3, Pages (November 2007)
Volume 14, Issue 2, Pages (February 2007)
Collapsing the Proton Motive Force to Identify Synergistic Combinations against Staphylococcus aureus  Maya A. Farha, Chris P. Verschoor, Dawn Bowdish,
Volume 20, Issue 12, Pages (December 2013)
Targeting the Undruggable Proteome: The Small Molecules of My Dreams
Volume 19, Issue 7, Pages (July 2012)
Volume 22, Issue 6, Pages (June 2015)
Volume 22, Issue 3, Pages (March 2015)
Volume 21, Issue 8, Pages (August 2014)
Small Molecule Fluoride Toxicity Agonists
Volume 14, Issue 7, Pages (July 2007)
How Chemoproteomics Can Enable Drug Discovery and Development
Structure-Guided Design of Fluorescent S-Adenosylmethionine Analogs for a High- Throughput Screen to Target SAM-I Riboswitch RNAs  Scott F. Hickey, Ming C.
Volume 14, Issue 10, Pages (October 2007)
Volume 18, Issue 11, Pages (November 2011)
Beena Krishnan, Lila M. Gierasch  Chemistry & Biology 
Volume 19, Issue 6, Pages (June 2012)
Volume 24, Issue 2, Pages (February 2017)
Volume 16, Issue 2, Pages (February 2009)
Volume 19, Issue 12, Pages (December 2012)
Volume 23, Issue 2, Pages (February 2016)
Maïlys A.S. Vergnolle, Stephen S. Taylor  Current Biology 
Volume 18, Issue 3, Pages (March 2011)
PARP Inhibitors: Staying on Target?
Volume 18, Issue 6, Pages (June 2011)
Volume 16, Issue 10, Pages (October 2009)
Volume 18, Issue 11, Pages (November 2011)
Volume 24, Issue 2, Pages (February 2017)
Volume 20, Issue 7, Pages (July 2013)
Volume 18, Issue 4, Pages (April 2011)
Volume 24, Issue 12, Pages e5 (December 2017)
Volume 24, Issue 11, Pages e8 (November 2017)
Volume 17, Issue 1, Pages (January 2010)
Volume 16, Issue 10, Pages (October 2009)
Volume 21, Issue 11, Pages (November 2014)
Volume 16, Issue 6, Pages (June 2009)
Inhibitor Mediated Protein Degradation
An Electrophoretic Mobility Shift Assay Identifies a Mechanistically Unique Inhibitor of Protein Sumoylation  Yeong Sang Kim, Katelyn Nagy, Samantha Keyser,
Volume 16, Issue 6, Pages (June 2009)
Volume 19, Issue 8, Pages (August 2012)
Anke Kiessling, Bianca Sperl, Angela Hollis, Dirk Eick, Thorsten Berg 
Volume 17, Issue 11, Pages (November 2010)
Dissecting RNA-Interference Pathway with Small Molecules
Volume 14, Issue 6, Pages (June 2007)
Volume 18, Issue 12, Pages (December 2011)
Protein Kinase D Inhibitors Uncouple Phosphorylation from Activity by Promoting Agonist-Dependent Activation Loop Phosphorylation  Maya T. Kunkel, Alexandra C.
UA62784 Is a Cytotoxic Inhibitor of Microtubules, not CENP-E
Volume 19, Issue 14, Pages (July 2009)
Volume 20, Issue 3, Pages (March 2013)
Volume 21, Issue 9, Pages (September 2014)
Discovery of Antagonist Peptides against Bacterial Helicase-Primase Interaction in B. stearothermophilus by Reverse Yeast Three-Hybrid  Laurence Gardiner,
Aaron T. Wright, Benjamin F. Cravatt  Chemistry & Biology 
Matthew D. Disney, Peter H. Seeberger  Chemistry & Biology 
Tariq A. Mukhtar, Kalinka P. Koteva, Gerard D. Wright 
Volume 21, Issue 12, Pages (December 2014)
Volume 18, Issue 11, Pages (November 2011)
Synthetic Chromatin Acylation by an Artificial Catalyst System
Volume 17, Issue 8, Pages (August 2010)
Volume 12, Issue 11, Pages (November 2005)
Volume 21, Issue 9, Pages (September 2014)
A New Fluorescence-Based Assay for Autophagy
Presentation transcript:

Volume 17, Issue 6, Pages 659-664 (June 2010) Chemical Proteomics Identifies Nampt as the Target of CB30865, An Orphan Cytotoxic Compound  Tracey C. Fleischer, Brett R. Murphy, Jeffrey S. Flick, Ryan T. Terry-Lorenzo, Zhong-Hua Gao, Thaylon Davis, Rena McKinnon, Kirill Ostanin, J. Adam Willardsen, J. Jay Boniface  Chemistry & Biology  Volume 17, Issue 6, Pages 659-664 (June 2010) DOI: 10.1016/j.chembiol.2010.05.008 Copyright © 2010 Elsevier Ltd Terms and Conditions

Figure 1 CB30865 Analogs Interact with Nampt (A) Quinazolinone structures. (B) Viability assay. Mean ATP levels of two replicates normalized to a vehicle control are plotted with the standard deviation. Chemistry & Biology 2010 17, 659-664DOI: (10.1016/j.chembiol.2010.05.008) Copyright © 2010 Elsevier Ltd Terms and Conditions

Figure 2 MPI-0479883 Interacts with Nampt (A) MPI-0479883 affinity purification. SDS-PAGE gel showing pull-downs with EA- or MPI-0479883-beads in the presence (+) or absence (−) of 10 μM uncoupled MPI-0479883 (Block). (B) LC-MS/MS analysis of pull-downs. The heat map indicates the total number of spectra corresponding to the listed proteins. (C) α-Nampt immunoblot of pull-downs. Lanes are the same as in (A). (D) Ruby-stained gel showing MPI-0479883 pull-downs blocked with vehicle (−), free MPI-0479883 (3p), or MPI-0482594 (2p). (E) Ruby-stained gel and α-Nampt immunoblot of pull-downs done with MPI-0479883 or MPI-0482594 in the presence (+) or absence (−) of 10 μM of their respective free compound (Block). Density of compound was varied by coupling at the concentrations indicated. Chemistry & Biology 2010 17, 659-664DOI: (10.1016/j.chembiol.2010.05.008) Copyright © 2010 Elsevier Ltd Terms and Conditions

Figure 3 MPI-0479883 Inhibits Nampt Activity In Vitro and In Vivo (A) Schematic of the in vitro Nampt assay. (B) Dose response of MPI-0479883 in the Nampt assay. Graphs indicate average Nampt activity (resorufin fluorescence) normalized to a vehicle control. The standard deviation between duplicate samples is shown. (C) PAR immunofluorescence assay. Cells treated with vehicle or MPI-0479883 and H2O2 where indicated were stained with α-PAR antibody and Hoechst to mark nuclei. (D) The PAR intensity for cells treated with MPI-0479883 in the presence or absence of NA was quantified and the mean from duplicate experiments plotted with the standard deviation. (E) NAD levels in cells treated with indicated amounts of MPI-0479883 in the presence (NA) or absence (vehicle) of 10 μM nicotinic acid. The mean and the standard error are shown. (F) Cytotoxicity of MPI-0479883 in the absence (vehicle) or presence (NA) of 10 μM nicotinic acid. Mean ATP levels of two replicates normalized to a vehicle control are plotted with the standard deviation. Chemistry & Biology 2010 17, 659-664DOI: (10.1016/j.chembiol.2010.05.008) Copyright © 2010 Elsevier Ltd Terms and Conditions